Considering we are still making revenue and new lines may soon add to the product mix, does this now represent an undervalued stock? I'm asking myself how much will earnings fall and if DPS holds at say (guessing now) 3.5 is that good value and what are the risks?
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-40
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46219 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 185000 | 2 |
View Market Depth
| Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable